Healthcare - Biotechnology - NASDAQ - CN
$ 1.04
-2.8 %
$ 80.1 M
Market Cap
-0.46
P/E
INCOME STATEMENT
27.6 M
REVENUE
-1.24 B
OPERATING INCOME
-207 M
NET INCOME
EFFICIENCY
Earnings Waterfall
I-Mab
| Revenue | 27.6 M |
| Cost Of Revenue | 0 |
| Gross Profit | 27.6 M |
| Operating Expenses | 201 M |
| Operating Income | -1.24 B |
| Other Expenses | -1.03 B |
| Net Income | -207 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 27.6 | (221.6) | 88.0 | 1 542.7 | 30.0 | 53.8 | 11.6 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 0 | 27.2 | 46.4 | 0 | 0 | 0 | 0 |
| Gross Profit | 27.6 | (248.8) | 41.6 | 1 542.7 | 30.0 | 53.8 | 11.6 |
| OPERATING INCOME | |||||||
| Operating Expenses | 201.2 | 2 284.7 | 2 397.6 | 1 082.8 | 1 509.5 | 461.4 | 310.6 |
| Selling, General and Administrative Expenses | 63.9 | 815.8 | 899.9 | 402.4 | 654.6 | 66.4 | 25.4 |
| Research and Development Expenses | 114.4 | 904.9 | 1 213.0 | 984.7 | 840.4 | 426.0 | 267.1 |
| Operating Income | (1 236.0) | (1 969.5) | (2 071.3) | 155.6 | (1 465.0) | (438.6) | (281.0) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 0.1 | 1.3 K | 0 | 0.1 | 0.4 | 1.7 | 0.9 |
| Total Other Income | (229.7) | (537.2) | (263.4) | 327.6 | 13.0 | 37.5 | (17.3) |
| Pre-Tax Income | (1 465.7) | (2 506.6) | (2 334.7) | 483.1 | (1 452.0) | (401.1) | (298.2) |
| NET INCOME | |||||||
| Tax Provision | (1 258.9) | 0.7 | 3.2 | 12.2 | 0 | 1.7 | 0 |
| Net Income | (1 465.7) | (2 507.3) | (2 331.5) | 470.9 | (1 485.0) | (402.8) | (298.2) |
| EPS | 17.6 | 30.4 | 30.7 | 8.07 | 463 | 142 | 119 |